Logo image of AWIN

AERWINS TECHNOLOGIES INC (AWIN) Stock Fundamental Analysis

NASDAQ:AWIN - Nasdaq - US00810J2078 - Common Stock - Currency: USD

1.74  -1.6 (-47.9%)

After market: 1.83 +0.09 (+5.17%)

Fundamental Rating

0

Overall AWIN gets a fundamental rating of 0 out of 10. We evaluated AWIN against 67 industry peers in the Aerospace & Defense industry. AWIN may be in some trouble as it scores bad on both profitability and health. AWIN has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

AWIN had negative earnings in the past year.
In the past year AWIN has reported a negative cash flow from operations.
AWIN Yearly Net Income VS EBIT VS OCF VS FCFAWIN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -5M -10M -15M -20M -25M

1.2 Ratios

The Return On Assets of AWIN (-2430.97%) is worse than 98.44% of its industry peers.
Industry RankSector Rank
ROA -2430.97%
ROE N/A
ROIC N/A
ROA(3y)-880.36%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AWIN Yearly ROA, ROE, ROICAWIN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -5K -10K -15K -20K -25K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for AWIN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AWIN Yearly Profit, Operating, Gross MarginsAWIN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -50 -100 -150

0

2. Health

2.1 Basic Checks

AWIN has more shares outstanding than it did 1 year ago.
AWIN has a worse debt/assets ratio than last year.
AWIN Yearly Shares OutstandingAWIN Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 200K 400K 600K
AWIN Yearly Total Debt VS Total AssetsAWIN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 5M 10M 15M 20M 25M

2.2 Solvency

Based on the Altman-Z score of -130.69, we must say that AWIN is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -130.69, AWIN is doing worse than 93.75% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -130.69
ROIC/WACCN/A
WACCN/A
AWIN Yearly LT Debt VS Equity VS FCFAWIN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 10M -10M

2.3 Liquidity

A Current Ratio of 0.08 indicates that AWIN may have some problems paying its short term obligations.
AWIN's Current ratio of 0.08 is on the low side compared to the rest of the industry. AWIN is outperformed by 98.44% of its industry peers.
AWIN has a Quick Ratio of 0.08. This is a bad value and indicates that AWIN is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.08, AWIN is doing worse than 98.44% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.08
Quick Ratio 0.08
AWIN Yearly Current Assets VS Current LiabilitesAWIN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 5M 10M 15M 20M

0

3. Growth

3.1 Past

AWIN shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.02%.
AWIN shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -100.00%.
EPS 1Y (TTM)6.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%84.25%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%48.24%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y111.11%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year76.14%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AWIN Yearly Revenue VS EstimatesAWIN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
AWIN Yearly EPS VS EstimatesAWIN Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 0 -5 -10 -15 -20

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AWIN. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 85.29, the valuation of AWIN can be described as expensive.
62.50% of the companies in the same industry are cheaper than AWIN, based on the Price/Forward Earnings ratio.
AWIN is valuated expensively when we compare the Price/Forward Earnings ratio to 34.04, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 85.29
AWIN Price Earnings VS Forward Price EarningsAWIN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AWIN Per share dataAWIN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -10 -20 -30 -40

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

AWIN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

AERWINS TECHNOLOGIES INC

NASDAQ:AWIN (6/18/2024, 8:14:32 PM)

After market: 1.83 +0.09 (+5.17%)

1.74

-1.6 (-47.9%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners255.89%
Ins Owner Change0%
Market Cap1.60M
Analysts82.86
Price Target1.02 (-41.38%)
Short Float %0.16%
Short Ratio0
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-102.73%
Min Revenue beat(2)-106.04%
Max Revenue beat(2)-99.42%
Revenue beat(4)0
Avg Revenue beat(4)-76.3%
Min Revenue beat(4)-106.04%
Max Revenue beat(4)-1.94%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 85.29
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-45.4
EYN/A
EPS(NY)0.02
Fwd EY1.17%
FCF(TTM)-7.15
FCFYN/A
OCF(TTM)-7.15
OCFYN/A
SpS0
BVpS-20.09
TBVpS-20.09
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2430.97%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-880.36%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.08
Quick Ratio 0.08
Altman-Z -130.69
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%84.25%
EPS Next Y111.11%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%48.24%
Revenue Next Year76.14%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-799700%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y63.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y61%
OCF growth 3YN/A
OCF growth 5YN/A